Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NVS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Novartis AG (NVS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novartis (NVS) trades at $151.03, up 6.05% today, showing strong momentum despite mixed quarterly earnings. The stock demonstrates robust fundamentals with a 74.74% gross margin and 22.5% net income margin, though valuation metrics appear elevated with a P/E of 22.19. Recent news highlights a major $7.8B licensing deal with China's Abogen for mRNA therapy development, potentially expanding the autoimmune disease pipeline.
The outlook remains cautiously optimistic with analyst consensus at 'Hold' (68%) and a $146 price target below current levels. Key risks include recent clinical trial setbacks and investor scrutiny of M&A strategy. Upside potential exists from pipeline expansion, but investors should weigh elevated valuation against growth prospects in a competitive pharmaceutical landscape.
Read full analysis

Key Stats

  • Market Cap
    $279.90B
  • Volume
    1,647,300
  • Sector
    Health
  • 52W High
    $168.62
  • 52W Low
    $121.80
  • Typical Hold Time
    82 Days
  • Enterprise Value
    $321.22B
  • Div Yield
    3.23%
  • Trading Activity
    35% Sell | 65% Buy
$150.8
52W Low: $121.8
29 Oct 2025
52W High: $168.62
27 Feb 2026

Track Novartis AG (NVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novartis AG has traded between a low of $121.8 and a high of $168.62, highlighting its annual price range. Buy and sell Novartis AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Most Recent News

Content is generated by Aura AI

Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

Copper exploration in British Columbia is increasingly relying on induced polarization (IP) geophysical surveys, which measure electrical chargeability and resistivity in rocks to identify sulphide mineralization associated with copper deposits. Gold...

Market News
54 minutes ago
Equity Insider
Bullish
news icon
Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

The S&P 500 index has increased by 30.6% during the first 20 months of Donald Trump's second presidential term, slightly surpassing the 28.5% gain recorded in the same period of his first term. This comparison is significant for investors as it provi...

Market News
1 hour ago
James Brumley
Neutral
S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally

The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...

Market News
2 hours ago
Delveinsight
Bullish
news icon
Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $279.90B
  • Volume
    1,647,300
  • Sector
    Health
  • 52W High
    $168.62
  • 52W Low
    $121.80
  • Typical Hold Time
    82 Days
  • Enterprise Value
    $321.22B
  • Div Yield
    3.23%
  • Trading Activity
    35% Sell | 65% Buy
$150.8
52W Low: $121.8
29 Oct 2025
52W High: $168.62
27 Feb 2026

Track Novartis AG (NVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novartis AG has traded between a low of $121.8 and a high of $168.62, highlighting its annual price range. Buy and sell Novartis AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!